Bank of America
CHRS icon

Bank of America’s Coherus Oncology CHRS Stock Holding History

Bank of America’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-27,000
Closed -$195K – 7867
2022
Q2 		$195K Buy
+27,000
New +$235K ﹤0.01% 6112
2021
Q1 		– Sell
-40,800
Closed -$709K – 7442
2020
Q4 		$709K Buy
+40,800
New +$726K ﹤0.01% 4765
2017
Q4 		– Sell
-13,700
Closed -$183K – 7039
2017
Q3 		$183K Sell
13,700
-58,000
-81% -$767K ﹤0.01% 5428
2017
Q2 		$1.03M Buy
+71,700
New +$1.38M ﹤0.01% 4413

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Bank of America's CHRS Position: Q1 2026 in Review

Bank of America increased its Coherus Oncology (CHRS) stake by 190% in Q1 2026, buying an estimated $377K and bringing the position to 324,133 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #4844.

Bank of America first reported a position in CHRS in Q1 2015 and has held it in 45 quarters since. The position peaked at $7.06M in Q4 2023. 158 funds tracked by Wall St. Rank hold CHRS as of Q1 2026.

  • Bank of America held 324,133 shares of Coherus Oncology worth $548K as of Q1 2026.
  • Bank of America bought 212,430 Coherus Oncology shares in Q1 2026, an estimated $377K.
  • Coherus Oncology made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4844 holding.
  • Bank of America first reported a position in Coherus Oncology in Q1 2015 and has held it in 45 quarters since.
  • Bank of America's Coherus Oncology position peaked at $7.06M in Q4 2023.
  • 158 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.